Publications

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.

Coronel, J; Roper, MH; Herrera, C; Bonilla, C; Jave, O; Gianella, C; Sabogal, I; Huancaré, V; Leo, E; Tyas, A; Mendoza-Ticona, A; Caviedes, L; MOORE, DA J;

2013

Clinical microbiology and infection, (2013).20 6 10.1111/1469-0691.12401.

Multidrug-resistant tuberculosis in UK children: presentation, management and outcome.

Williams, B; Ramroop, S; Shah, P; Anderson, L; Das, S; Riddell, A; Liebeschuetz, S; BASU ROY, R; O'Callaghan, M; Sloper, K; Bernatoniene, J; Shingadia, D; KAMPMANN, B;

2013

The European respiratory journal, (2013).41 6 10.1183/09031936.00179712.

Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.

MacPherson, P; HOUBEN, RM G J; GLYNN, JR; CORBETT, EL; KRANZER, K;

2013

Bulletin of the World Health Organization, (2013).92 2 10.2471/BLT.13.124800.

Diagnosis of pulmonary tuberculosis.

LAWN, SD;

2013

Current opinion in pulmonary medicine, (2013).19 3 10.1097/MCP.0b013e32835f1b70.

Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.

Hur, Y-G; GORAK-STOLINSKA, P; Ben-Smith, A; Lalor, MK; Chaguluka, S; Dacombe, R; Doherty, TM; Ottenhoff, TH; DOCKRELL, HM; CRAMPIN, AC;

2013

PloS one, (2013).8 11 10.1371/journal.pone.0079742.

Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis.

LAWN, SD; Kerkhoff, AD; Vogt, M; Wood, R;

2013

The international journal of tuberculosis and lung disease, (2013).17 5 10.5588/ijtld.12.0811.

Eligibility for isoniazid preventive therapy in South African gold mines.

LEWIS, JJ; FIELDING, KL; GRANT, AD; Chihota, VN; Popane, F; Luttig, M; Muller, D; Coetzee, L; CHURCHYARD, GJ;

2013

PloS one, (2013).8 11 10.1371/journal.pone.0081376.

HIV testing in people with presumptive tuberculosis: time for implementation.

Kumar, AM V; Gupta, D; Gupta, RS; Satyanarayana, S; Wilson, N; Zachariah, R; Lawn, SD; Harries, AD;

2013

The lancet Respiratory medicine, (2013).1 1 10.1016/S2213-2600(12)70050-4.

Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.

Ugarte-Gil, CA; Elkington, P; Gilman, RH; Coronel, J; Tezera, LB; BERNABE-ORTIZ, A; Gotuzzo, E; Friedland, JS; MOORE, DA J;

2013

PLoS One, (2013).8 4 10.1371/journal.pone.0061333.

Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity.

SUTHERLAND, JS; Loxton, AG; Haks, MC; Kassa, D; Ambrose, L; LEE, J-S; Ran, L; Van Baarle, D; Maertzdorf, J; Howe, R; Mayanja-Kizza, H; Boom, WH; Thiel, BA; CRAMPIN, AC; Hanekom, W; Ota, MO C; DOCKRELL, H; Walzl, G; Kaufmann, SH E; Ottenhoff, TH M; GCGH Biomarkers for TB consortium,;

2013

Clinical microbiology and infection, (2013).20 4 10.1111/1469-0691.12383.